Publications by authors named "Athar Parvez Ansari"

Diabetes mellitus (DM) is a decisive risk factor for severe illness in coronavirus disease 2019 (COVID-19). India is home to a large number of people with DM, and many of them were infected with COVID-19. It is critical to understand the impact of DM on mortality and other clinical outcomes of COVID-19 infection from this region.

View Article and Find Full Text PDF

Objectives: To validate the concept of (drug substitution) by evaluation of physicochemical standardization and hepatoprotective activity of & its substitute, in albino Wistar rats.

Methods: Physicochemical standardization by estimation of moisture content, ash values and extractive values were carried out using standard methods. Hepatotoxicity was induced in albino Wistar rats using CCl 1 mL/kg s.

View Article and Find Full Text PDF

Since antiquity, the Unani system of medicine has been participating in health care system. Usually, four modes of treatment viz. regimenal therapy, dietotherapy, pharmacotherapy and surgery are applied for the treatment of diseases.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Athar Parvez Ansari"

  • - Athar Parvez Ansari's research predominantly focuses on the intersection of traditional medicine and modern health challenges, particularly the impact of diabetes on COVID-19 outcomes and the validation of traditional Unani medicine practices.
  • - One significant study analyzed the mortality and clinical outcomes of COVID-19 patients with diabetes in India, highlighting the increased risks associated with the condition in a densely populated region.
  • - Another key piece of research involved the validation of drug substitution in Unani medicine, specifically examining the hepatoprotective properties of certain herbal remedies, thus bridging the gap between traditional healing practices and contemporary pharmacological standards.